Company Annexin Pharmaceuticals AB (publ) Nasdaq Stockholm
Equities
ANNX BTA
SE0013748894
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- SEK | -.--% | -3.17% | -.--% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Anna Frostegård
FOU | Founder | 51 | 01/14/01 |
Chief Executive Officer | 63 | 01/18/01 | |
Director of Finance/CFO | 53 | 11/23/11 | |
Susan Suchdev
COO | Chief Operating Officer | 52 | - |
Alain Thibault
PRN | Corporate Officer/Principal | - | 18/23/18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
CHM | Chairman | 74 | 01/21/01 |
Mårten Österlund
BRD | Director/Board Member | 67 | 01/21/01 |
Chief Executive Officer | 63 | 01/18/01 | |
Director/Board Member | 48 | 01/17/01 | |
Director/Board Member | 65 | 01/16/01 | |
Director/Board Member | 66 | 01/17/01 | |
Director/Board Member | 71 | - | |
Anthon Jahreskog
BRD | Director/Board Member | 44 | 01/22/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 526,807,199 | 256,124,467 ( 48.62 %) | 0 | 48.62 % |
Company contact information
Sector
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+15.55% | 121B | |
+12.66% | 107B | |
-2.53% | 24.82B | |
+1.14% | 22.48B | |
-9.35% | 18.32B | |
-42.28% | 16.33B | |
-18.92% | 15.31B | |
+6.19% | 14.08B | |
+28.83% | 11.74B |
- Stock Market
- Equities
- ANNX Stock
- ANNX BTA Stock
- Company Annexin Pharmaceuticals AB (publ)